Skip to main content
Market intelligence
FULCHealthcare

Fulcrum Therapeutics Inc insider activity

In the last 90 days, 2 corporate insiders purchased $2,971,451 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$2,971,451
Corporate buyers
2
Latest transaction
Jul 17, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jul 17, 2026Kevin Tang10% OwnerOpen Market Purchase167,616$3.55$594,668
Jul 17, 2026Tang Capital Management LlcCorporate insiderOpen Market Purchase167,616$3.55$594,668
Jul 15, 2026Kevin Tang10% OwnerOpen Market Purchase249,946$3.57$891,057